136 related articles for article (PubMed ID: 17311818)
1. General principles of treatment.
Schouten HC
Ann Oncol; 2007 Jan; 18 Suppl 1():i29-i32. PubMed ID: 17311818
[No Abstract] [Full Text] [Related]
2. Response evaluation and long-term follow-up.
Schouten HC
Ann Oncol; 2007 Jan; 18 Suppl 1():i33-i36. PubMed ID: 17311820
[No Abstract] [Full Text] [Related]
3. 2nd International Congress on Leukemia, Lymphoma and Myeloma.
Arat M; Ozsan GH; Yenerel MN; Cetin M; Ozcan M
Expert Rev Hematol; 2009 Oct; 2(5):509-12. PubMed ID: 21083016
[TBL] [Abstract][Full Text] [Related]
4. Current awareness in hematological oncology.
Hematol Oncol; 1995; 13(2):109-18. PubMed ID: 7797193
[No Abstract] [Full Text] [Related]
5. Current awareness in hematological oncology.
Hematol Oncol; 1995; 13(1):49-58. PubMed ID: 7750928
[No Abstract] [Full Text] [Related]
6. [Interferon in the therapy of hemoblastoses (a review)].
Iavorkovskiĭ LI; Iavorkovskiĭ LL
Ter Arkh; 1989; 61(10):33-9. PubMed ID: 2481891
[No Abstract] [Full Text] [Related]
7. [Interferons: Clinical applications in hematology].
Ben Rhomdhane N; Ben Ahmed M; Zitouni M; Mtimet B
Tunis Med; 1998 Dec; 76(12):427-36. PubMed ID: 10093482
[No Abstract] [Full Text] [Related]
8. [Treatment of hematologic diseases with alpha interferon].
Castaigne S
Bull Cancer; 1988; 75(9):859-62. PubMed ID: 3207895
[TBL] [Abstract][Full Text] [Related]
9. Recent publications in hematological oncology.
Hematol Oncol; 2007 Sep; 25(3):148-55. PubMed ID: 17957827
[No Abstract] [Full Text] [Related]
10. [Malignant hematologic diseases. Diagnosis and treatment. A clearing report].
Birgens H; Christensen BE; Hansen NE; Jensen MK; Junker K; Jørgensen FS; Nielsen JL; Nissen NI
Ugeskr Laeger; 1991 Jun; 153(23):1638-47. PubMed ID: 2058026
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation.
Lin CJ; Vader JM; Slade M; DiPersio JF; Westervelt P; Romee R
Cancer; 2017 May; 123(10):1800-1809. PubMed ID: 28262921
[TBL] [Abstract][Full Text] [Related]
12. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1990; 11():321-42. PubMed ID: 2223398
[No Abstract] [Full Text] [Related]
13. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1992; 13():327-48. PubMed ID: 1389914
[No Abstract] [Full Text] [Related]
14. Topics in pediatric leukemia--myelodysplastic and myeloproliferative disorders of childhood.
Lasky J; Sakamoto KM
MedGenMed; 2005 Mar; 7(1):21. PubMed ID: 16369326
[No Abstract] [Full Text] [Related]
15. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1991; 12():327-46. PubMed ID: 1931449
[No Abstract] [Full Text] [Related]
16. Salient features of hematological diseases.
Fey MF
Ann Oncol; 2007 Jan; 18 Suppl 1():i54-i64. PubMed ID: 17311824
[No Abstract] [Full Text] [Related]
17. The interferons in haematological malignancies.
Mandelli F; Arcese W; Avvisati G
Baillieres Clin Haematol; 1994 Mar; 7(1):91-113. PubMed ID: 7518713
[TBL] [Abstract][Full Text] [Related]
18. [Clinical use of alpha-interferon in onco-hematology: conclusions and prospects].
Bernasconi C
Haematologica; 1990; 75 Suppl 4():82-4. PubMed ID: 2074058
[No Abstract] [Full Text] [Related]
19. Adoptive immunotherapy in human and canine chimeras--the role of interferon alfa. EBMT Chronic Leukemia Working Party.
Kolb HJ; Mittermüller J; Hertenstein H; Schumm M; Holler E; de Witte T; Günther W; Ljungman P; Goldman JM
Semin Hematol; 1993 Jul; 30(3 Suppl 3):37-9. PubMed ID: 8235705
[No Abstract] [Full Text] [Related]
20. [Bone marrow transplantation--rapid development towards new indications].
Gahrton G; Ringdén O; Robert KH
Lakartidningen; 1988 Mar; 85(9):689-91, 695. PubMed ID: 3280928
[No Abstract] [Full Text] [Related]
[Next] [New Search]